Volunteer Donate Get Help

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

U.S. Senate Introduces Cancer Drug Parity Act

Published: December 12, 2018

Source: Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (LLS) is proud to support the Cancer Drug Parity Act. which will ensure equality of insurance coverage for all cancer treatments, regardless of how these treatments are ad ... More >>.

Tailoring Treatment for AML

Published: December 07, 2018

Source: University of Washington Heath Science

Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).

Research on the dru ... More >>.

Combination Chemotherapy and Immunotherapy Effective

Published: November 08, 2018

Source: University of Texas M.D. Anderson Cancer Center

A combination of the standard-of-care chemotherapy drug know as azacytidine, with nivolumab, an immune checkpoint inhibitor, demonstrated an encouraging response rate and overall survival in patients with re ... More >>.

LLS Committing $188 Million

Published: November 08, 2018

Source: Leukemia & Lymphoma Society

Driving the dizzying pace of breakthroughs in blood cancer treatments, The Leukemia & Lymphoma Society (LLS) announced today $42 million for 80 blood cancer research teams around the world.

The l ... More >>.

Tackling EBV-Associated Lymphoma

Published: November 01, 2018

Author: Susan Jenks

Source: Cancer Therapy Advisor

Donor-derived T cells that target proteins of the Epstein-Barr virus (EBV) in relapsed or refractory lymphoma can improve overall survival in the adjuvant setting, according to research from a small study th ... More >>.

Leukemia Dataset Match Therapies to Patients

Published: October 17, 2018

Source: Howard Hughes Medical Institute

After years of work, researchers are releasing a massive dataset detailing the molecular makeup of tumor cells from more than 500 patients with an aggressive blood cancer called acute myeloid leukemia (AML). ... More >>.

ADC for Non-Hodgkin Lymphoma

Published: October 16, 2018

Author: Bryant Furlow

Source: Cancer Therapy Advisor

The Leukemia & Lymphoma Society (LLS) and Sutro Biopharma have partnered for a phase 1 clinical study of the firm's first-in-class, CD74-targeting antibody-drug conjugates (ADC) STRO-001 against refracto ... More >>.

Funding Increase for Cancer Research

Published: September 26, 2018

Source: Leukemia & Lyphoma Society

The Leukemia & Lymphoma Society (LLS) commends the U.S. House of Representatives for approving a funding package today that will provide much-needed additional resources for federal cancer research effor ... More >>.

Novel Treatment for HCL

Published: September 18, 2018

Source: Oncology Nurse Advisor

Lumoxiti (moxetumomab pasudotox-tdfk) injection has been approved to treat certain instances of relapsed or refractory hairy cell leukemia (HCL), the U.S. Food & Drug Administration said yesterday.

... More >>.

Baffling High-Risk Leukemia Solved

Published: September 12, 2018

Source: St. Jude Children's Research Hospital

St. Jude Children's Research Hospital investigators have unraveled the origins and identified mutations with a perplexing form of acute leukemia, The landmark study appears today as an advance online publica ... More >>.

©2015 Stephanie Robinson Foundation | Privacy Policy